Gastrointest Endosc 2002 Mar;55(3):451-3
J Inflamm Res 2021 13;14:3231-3245. Epub 2021 Jul 13.
School of Clinical Medicine, Tsinghua University, Beijing, 100084, People's Republic of China.
Purpose: Previous studies have shown that various preoperative inflammatory indicators can predict the prognosis of hepatocellular carcinoma (HCC), but the role of postoperative inflammatory indicators remains unclear. This study aimed to explore the prognostic value of postoperative inflammatory indicators and whether combining preoperative and postoperative inflammatory indicators can improve the predictive performance of the prognostic model.Patients And Methods: Eighty-eight patients with primary HCC were included in this study. Read More
World J Surg 2021 Jul 17. Epub 2021 Jul 17.
Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Background: This study aimed to assess an oncologic setting where patients with hepatocellular carcinoma (HCC) could benefit from liver resection (LR) compared to living donor liver transplantation (LDLT) using F-fluorodeoxyglucose (FDG) positron emission tomography.Methods: The consecutive data of patients with HCC who underwent F-FDG PET before LR (LR group, n = 314) and LDLT (LDLT group, n = 65) between 2003 and 2015 were retrospectively analyzed. Tumor F-FDG avidity was quantified as the tumor to liver standardized uptake value ratio (TLR, cut-off value was defined at 2). Read More
Gut 2021 Jul 16. Epub 2021 Jul 16.
Gastroenterology and Hepatology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Objective: Following an episode of acute biliary pancreatitis, cholecystectomy is advised to prevent recurrent biliary events. There is limited evidence regarding the optimal timing and safety of cholecystectomy in patients with necrotising biliary pancreatitis.Design: A post hoc analysis of a multicentre prospective cohort. Read More
Front Oncol 2021 28;11:676092. Epub 2021 Jun 28.
Department of Ultrasound Diagnostics, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Apatinib is a new oral tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor-2. It has been proven effective in treating multiple solid tumors. Herein, we report the case of a 67-year-old Chinese patient who was diagnosed with recurrent and malignant transformation of intrahepatic biliary cystadenoma. Read More
Pathol Oncol Res 2021 30;27:628323. Epub 2021 Mar 30.
Department of Hepatobiliary Surgery, General Surgery, Qilu Hospital of Shandong University, Ji'nan, China.
Multicystic biliary hamartoma (MCBH) is an extremely rare cystic lesion of the liver. A 37-year old male patient was admitted to our hospital for incidentally discovered hepatic cystic lesions on abdominal ultrasonography. Abdominal contrast-enhanced computed tomography (CT) showed a multilocular cystic lesion in the segment VI, with mild enhancement in the septae and peripheral wall within the lesion. Read More